Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-aminopyridine for peripheral nerve continuity diagnosis
NCT06003166Phase 2Recruiting
- Sponsor
- University of Arizona
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in peripheral nerve injury (PNI), sponsored by University of Arizona. Started Apr 2025; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT06003166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06003166.